| Expression pattern: |
UP |
| Associated gene: |
IGF1, Ago2 |
| Associated microRNA: |
miR-489-3p |
| Biological function: |
Promotes chemoresistance (PTX/DDP/DTX resistance) and proliferation in paclitaxel-resistant NSCLC cells. |
| Molecular mechanism: |
Acts as a ceRNA by sponging miR-489-3p to increase IGF1 expression, thereby enhancing chemoresistance. |
| Biological pathway or process: |
chemoresistance (promotes); proliferation (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Survival Analysis; Transfection; MTT; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); ELISA |
| Clinical significance: |
High hsa_circ_0003220 expression is associated with shorter overall survival in NSCLC patients. |
| Description: |
hsa_circ_0003220 is up-regulated in paclitaxel-resistant NSCLC tissues and cell lines and promotes proliferation and resistance to PTX/DDP/DTX. Mechanistically, it sponges miR-489-3p to increase IGF1 expression (miR-489-3p/IGF1 axis). High hsa_circ_0003220 expression correlates with shorter overall survival in NSCLC patients. |
| Confidence score: |
0.7238 |